NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration

In 2014 the Company entered into a license agreement with Merck to develop, manufacture and commercialize NewLink Genetics’ Ebola vaccine candidate AMES, Iowa, Nov. 15, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) reported today that Merck has...

read more

Nebullam awarded $100,000 in Demonstration Funds

AMES, Iowa (September 25, 2018) - The Iowa State University Startup Factory (SUF) today announced the Iowa Economic Development Authority (IEDA) board has awarded Nebullam $100,000 in innovation funds as recommended by the Technology Commercialization Committee....

read more

ISU Research Park receives $1.7 million grant

The following article was originally published on September 24, 2018 via Clay & Milk By Jake Slobe Iowa State University Research Park has been awarded a $1.7 million grant from the Economic Development Administration (EDA) to make critical infrastructure improvements...

read more